|
FY2025
12 months to Dec 31, 2025
|
FY2024
7 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net Income Loss | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Payment of formation and general costs through promissory note | ||
| Interest income on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Long-term prepaid insurance | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Units | ||
| Proceeds from promissory note - related party | ||
| Proceeds from convertible promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Noncash investing and financing activities: | ||
| Offering costs included in accrued offering costs | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Deferred offering costs paid through promissory note – related party | ||
| Deferred underwriting fee payable |
Loading...
